ICD-10-CM Billable Code

H11.022

Central pterygium of left eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Central pterygium of the left eye is a benign growth of conjunctival tissue that extends onto the cornea, the clear front surface of the eye. This condition typically develops slowly and can affect vision and eye comfort. It is characterized by a wedge-shaped tissue growth that starts from the inner corner of the eye (medial side) and progresses toward the central cornea. While often harmless, if left untreated or if it enlarges significantly, it can cause visual disturbances, irritation, or discomfort. Understanding this condition can help patients recognize symptoms early and seek appropriate eye care.

Causes & Symptoms

Clinical Causes: Prolonged exposure to ultraviolet (UV) light from the sun Chronic eye irritation from dust, wind, or dry environments Environmental factors such as wind, dust, and pollution Genetic predisposition or family history of pterygium Repeated trauma or injury to the eye Underlying chronic eye conditions causing irritation

Key Symptoms: A visible growth or fleshy tissue on the conjunctiva, particularly toward the inner corner of the eye Redness and inflammation in the affected area A sensation of dryness or itchiness in the eye Blurring or obstruction of vision if the growth progresses onto the cornea A feeling of foreign body presence or irritation Possible increase in size over time

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by an ophthalmologist. The doctor will inspect the eye for characteristic tissue growth, noting its size, location, and extent. Slit-lamp biomicroscopy is often used to assess the pterygium's impact on the cornea and surrounding tissues. In some cases, additional imaging or measurement of corneal curvature may be performed to evaluate any effect on vision. No specialized laboratory tests are usually needed for diagnosis.

Treatment Protocols: Observation: Small, asymptomatic pterygiums may just be monitored regularly for changes in size or symptoms. Medical management: Use of artificial tears or lubricating eye drops can alleviate dryness and irritation. Anti-inflammatory medications: Topical corticosteroids may be prescribed to reduce inflammation and redness. Surgical removal: For larger pterygiums causing visual impairment or significant discomfort, surgical excision may be recommended. Postoperative measures include the use of eye drops, medications, and follow-up visits to monitor healing and prevent recurrence. Preventive strategies: Wearing sunglasses and protective eyewear, avoiding excessive sun exposure, and maintaining eye comfort can reduce the risk of pterygium growth.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H11.022 a billable ICD-10 code?
Yes, H11.022 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H11.022?
Clinical documentation must specify the nature of Central pterygium of left eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference